Original Research
Accepted on 04 Nov 2024
ARMH1 is a novel marker associated with poor pediatric AML outcomes that affect the fatty acid synthesis and cell cycle pathways.
in Pediatric Oncology
- 100 views
Original Research
Accepted on 04 Nov 2024
in Pediatric Oncology
Original Research
Accepted on 04 Nov 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Accepted on 04 Nov 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 04 Nov 2024
in Breast Cancer
Correction
Accepted on 04 Nov 2024
in Molecular and Cellular Oncology
Case Report
Accepted on 04 Nov 2024
in Surgical Oncology
Original Research
Accepted on 04 Nov 2024
in Cancer Imaging and Image-directed Interventions
Original Research
Published on 04 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 04 Nov 2024
in Radiation Oncology
Review
Published on 04 Nov 2024
in Molecular and Cellular Oncology
Original Research
Published on 04 Nov 2024
in Thoracic Oncology
Original Research
Published on 04 Nov 2024
in Breast Cancer
Case Report
Published on 04 Nov 2024
in Breast Cancer
Editorial
Published on 04 Nov 2024
in Thoracic Oncology
Case Report
Published on 04 Nov 2024
in Gastrointestinal Cancers: Colorectal Cancer
Review
Published on 04 Nov 2024
in Cancer Genetics